Both in Pharmaceuticals
Onconetix vs Mustang Bio
Over the past year ONCO returned −99.5% and MBIO returned −69.5%; their daily moves had a correlation of 0.06.
ONCO −99.5% MBIO −69.5%Growth of $1, one year, split-adjusted
| Metric | ONCO | MBIO |
|---|---|---|
| Price | $0.8200 | $0.4796 |
| Market cap | $3.6M | $3.6M |
| Today | −26.13% | −5.39% |
| 1 month | +33.9% | −10.8% |
| 6 months | −94.8% | −33.9% |
| Year to date | −98.9% | −51.1% |
| 1 year | −99.5% | −69.8% |
| Revenue growth (YoY) | −83.9% | — |
| Gross margin | 25.1% | — |
| Net margin | −16748.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.6× | — |
| Net cash | $5.8M | $15.2M |
| Dividend yield | — | — |
| Volatility (60d) | 161.1% | 58.0% |
| Short % of float | 4.1% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).